Study protocol: The DAICY trial-dual versus single-antibiotic impregnated cement in primary hemiarthroplasty for femoral neck fracture-a register-based cluster-randomized crossover-controlled trial

Sebastian Mukka, Nils P Hailer, Michael Möller, Max Gordon, Stergios Lazarinis, Cecilia Rogmark, Ollie Östlund, Olof Sköldenberg, Olof Wolf, DAICY study group, Jonas Åhlander, Danyar Barneh, Mark Kruse, Maria Thorén Örnberg, Algirdas Petrauskas, Jonas Sundkvist, Thomas Stålarm, Lars Holgén, Anna Berggren, Daniel Stam, Bjerome Ahlin Henrik, Olof Leonardsson, Leif Mattisson, Per-Erik Johansson, Per Hulenvik, Per Fischer, Fredrik Sundström, Sebastian Mukka, Nils P Hailer, Michael Möller, Max Gordon, Stergios Lazarinis, Cecilia Rogmark, Ollie Östlund, Olof Sköldenberg, Olof Wolf, DAICY study group, Jonas Åhlander, Danyar Barneh, Mark Kruse, Maria Thorén Örnberg, Algirdas Petrauskas, Jonas Sundkvist, Thomas Stålarm, Lars Holgén, Anna Berggren, Daniel Stam, Bjerome Ahlin Henrik, Olof Leonardsson, Leif Mattisson, Per-Erik Johansson, Per Hulenvik, Per Fischer, Fredrik Sundström

Abstract

Background and purpose: Older patients with a displaced femoral neck fracture (FNF) are often treated with a cemented primary hemiarthroplasty (HA). The DAICY trial investigates whether high-dose dual-impregnated antibioticloaded cement (DIAC) including gentamicin and clindamycin can reduce the risk of periprosthetic joint infection (PJI) in comparison with low-dose single-impregnated gentamicin antibiotic-loaded cement (SIAC), in patients ≥ 60 years treated with a cemented HA for a displaced FNF.

Study design: The trial is a national, multicenter, register-based, cluster-randomized, crossover trial. Patients ≥ 60 years with a non-pathological, displaced FNF (Type Garden 3-4/AO 31-B2 or B3) suitable for HA according to local guidelines are eligible for inclusion. Participating orthopedic departments will be randomized to start with either SIAC (control group) or DIAC treatment (intervention group) for 2 years. After 2 years, the study departments will then change to the other treatment arm for the remaining 2 years of the study. Approximately 7,000 patients will be included. The study is pragmatic in that the choice of implant brands, surgical approach and peri- and postoperative protocols follow the local routines of each participating department. All outcome variables will be retrieved after linkage of the study cohort to the following Swedish registers: the Fracture Register, the Arthroplasty Register, the National Patient Register and the Prescribed Drug Registry Outcome: The primary outcome will be periprosthetic joint infection of the index joint within 1 year after surgery. Secondary outcomes will be any reoperation on the index joint, mortality within 90 days and 1 year, resistance patterns of causative bacteria in cases of PJI, and health economics. Potential added value: This trial is designed to support or refute the efficacy of DIAC used in patients with a displaced FNF, potentially reducing PJI and resource allocation. Start of the trial and estimated duration - The DAICY trial started recruiting patients in January 2022 and will continue recruiting for approximately 4 years. Complete follow-up expected in 5 years.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/9535850/bin/ActaO-93-4819-g001.jpg
Illustration of the study design

References

    1. Bhandari M, Swiontkowski M. Management of acute hip fracture. N Engl J Med 2017; 377(21): 2053-62. doi: 10.1056/NEJMcp1611090.
    1. Sundkvist J, Bruggeman A, Sayed-Noor A, Moller M, Wolf O, Mukka S. Epidemiology, classification, treatment, and mortality of adult femoral neck and basicervical fractures: an observational study of 40,049 fractures from the Swedish Fracture Register. J Orthop Surg Res 2021; 16(1): 561. doi: 10.1186/s13018-021-02701-1.
    1. Swedish Hip Arthroplasty Register . Annual Report 2021; 2022. [cited 2022]. Available from: .
    1. Parker M J, Cawley S. Cemented or uncemented hemiarthroplasty for displaced intracapsular fractures of the hip: a randomized trial of 400 patients. Bone Joint J 2020; 102-B(1): 11-16. doi: 10.1302/0301-620X.102B1.BJJ-2019-1041.R1.
    1. Viberg B, Pedersen A B, Kjaersgaard A, Lauritsen J, Overgaard S. Risk of mortality and re-operation in hip fracture patients undergoing cemented versus uncemented hemiarthroplasty: a population-based study from Danish National Registries. Bone Joint J 2022; 104-B(1): 127-33. doi: 10.1302/0301-620X.104B1.BJJ-2021-0523.R1.
    1. Fernandez M A, Achten J, Parsons N, Griffin X L, Png M E, Gould J, et al. . Cemented or Uncemented hemiarthroplasty for intracapsular hip fracture. N Engl J Med 2022; 386(6): 521-30. doi: 10.1056/NEJMoa2108337.
    1. Edwards C, Counsell A, Boulton C, Moran C G. Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 2008; 90(6): 770-7. doi: 10.1302/0301-620X.90B6.20194.
    1. Guren E, Figved W, Frihagen F, Watne L O, Westberg M. Prosthetic joint infection: a devastating complication of hemiarthroplasty for hip fracture. Acta Orthop 2017; 88(4): 383-9. doi: 10.1080/17453674.2017.1301009.
    1. Noailles T, Brulefert K, Chalopin A, Longis P M, Gouin F. What are the risk factors for post-operative infection after hip hemiarthroplasty? Systematic review of literature. Int Orthop 2016; 40(9): 1843-8. doi: 10.1007/s00264-015-3033-y.
    1. Voigt J, Mosier M, Darouiche R. Systematic review and meta-analysis of randomized controlled trials of antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses. Antimicrob Agents Chemother 2015; 59(11): 6696-707. doi: 10.1128/AAC.01331-15.
    1. Zhang J, Zhang X Y, Jiang F L, Wu Y P, Yang B B, Liu Z Y, et al. . Antibiotic-impregnated bone cement for preventing infection in patients receiving primary total hip and knee arthroplasty: a meta-analysis. Medicine (Baltimore) 2019; 98(49): e18068. doi: 10.1097/MD.0000000000018068.
    1. Swedish Hip Arthroplasty Register. Annual Report 2019; 2020. [cited 2022 Mar 06]. Available from: .
    1. Sprowson A P, Jensen C, Chambers S, Parsons N R, Aradhyula N M, Carluke I, et al. . The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip: the Fractured Hip Infection trial. Bone Joint J 2016; 98-B(11): 1534-41. doi: 10.1302/0301-620X.98B11.34693.
    1. Ensing G T, van Horn J R, van der Mei H C, Busscher H J, Neut D. Copal bone cement is more effective in preventing biofilm formation than Palacos R-G. Clin Orthop Relat Res 2008; 466(6): 1492-8. doi: 10.1007/s11999-008-0203-x.
    1. Thornes B, Murray P, Bouchier-Hayes D. Development of resistant strains of Staphylococcus epidermidis on gentamicin-loaded bone cement in vivo. J Bone Joint Surg Br 2002; 84(5): 758-60. doi: 10.1302/0301-620x.84b5.11907.
    1. Tyas B, Marsh M, Oswald T, Refaie R, Molyneux C, Reed M. Antibiotic resistance profiles of deep surgical site infections in hip hemiarthroplasty; comparing low dose single antibiotic versus high dose dual antibiotic impregnated cement. J Bone Jt Infect 2018; 3(3): 123-9. doi: 10.7150/jbji.22192.
    1. Knutsson S B, Wennergren D, Bojan A, Ekelund J, Moller M. Femoral fracture classification in the Swedish Fracture Register: a validity study. BMC Musculoskelet Disord 2019; 20(1): 197. doi: 10.1186/s12891-019-2579-z.
    1. Swedish Hip Arthroplasty Register . Annual Report 2018; 2019.
    1. Ludvigsson J F, Andersson E, Ekbom A, Feychting M, Kim J L, Reuterwall C, et al. . External review and validation of the Swedish national inpatient register. BMC Public Health 2011; 11: 450. doi: 10.1186/1471-2458-11-450.
    1. Lindgren J V, Gordon M, Wretenberg P, Kärrholm J, Garellick G. Validation of re-operations due to infection in the Swedish Hip Arthroplasty Register. BMC Musculoskelet Disord 2014; 15: 384. doi: 10.1186/1471-2474-15-384.
    1. Mellner C, Eisler T, Knutsson B, Mukka S. Early periprosthetic joint infection and debridement, antibiotics and implant retention in arthroplasty for femoral neck fracture. Hip Int 2017; 27(4): 349-53. doi: 10.5301/hipint.5000467.
    1. Mukka S, Mellner C, Knutsson B, Sayed-Noor A, Skoldenberg O. Substantially higher prevalence of postoperative peri-prosthetic fractures in octogenarians with hip fractures operated with a cemented, polished tapered stem rather than an anatomic stem. Acta Orthop 2016; 87(3): 257-61. doi: 10.3109/17453674.2016.1162898.
    1. Forbes A B, Akram M, Pilcher D, Cooper J, Bellomo R. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care. Clin Trials 2015; 12(1): 34-44. doi: 10.1177/1740774514559610.
    1. Morgan K E, Forbes A B, Keogh R H, Jairath V, Kahan B C. Choosing appropriate analysis methods for cluster randomised crossover trials with a binary outcome. Stat Med 2017; 36(2): 318-33. doi: 10.1002/sim.7137.
    1. Agni N R, Costa M L, Achten J, O’Connor H, Png M E, Peckham N, et al. . A randomized clinical trial of low dose single antibiotic-loaded cement versus high dose dual antibiotic-loaded cement in patients receiving a hip hemiarthroplasty after fracture: a protocol for the WHiTE 8 COPAL study. Bone Jt Open 2021; 2(2): 72-8. doi: 10.1302/2633-1462.22.BJO-2020-0174.
    1. Mukka S, Sjoholm P, Chammout G, Kelly-Pettersson P, Sayed-Noor A S, Skoldenberg O. External validity of the HOPE-Trial: hemiarthroplasty compared with total hip arthroplasty for displaced femoral neck fractures in octogenarians. JB JS Open Access 2019; 4(2): e0061. doi: 10.2106/JBJS.OA.18.00061.
    1. Moller M, Wolf O, Bergdahl C, Mukka S, Rydberg E M, Hailer N P, et al. . The Swedish Fracture Registe: ten years of experience and 600,000 fractures collected in a National Quality Register. BMC Musculoskelet Disord 2022; 23(1): 141. doi: 10.1186/s12891-022-05062-w.
    1. Wennergren D, Ekholm C, Sandelin A, Moller M. The Swedish fracture register: 103,000 fractures registered. BMC Musculoskelet Disord 2015; 16: 338. doi: 10.1186/s12891-015-0795-8.

Source: PubMed

3
Subscribe